Translate page

Meetings

Education

    CML publications

    Please find below a selection of interesting articles on CML from peer-reviewed journals. Recent publications include:


    Clinical CML papers
     

    Scientific CML papers

    More CML Publications 2026

    Clinical Publications Scientific Publications
    February 2026
    Secondary chronic myeloid leukemia in the blast phase with mixed phenotype after radiation therapy: A Case Report
    Aoki M et al. EJHaem, February 2026 
    – open access publication 
    ATTEC-mediated degradation of BCR-ABL in chronic myeloid leukemia cells
    Wang Z et al. Eur J Med Chem, February 2026

     

    Integrative multi-omics analysis of long non-coding RNA regulatory networks in chronic myeloid leukemia resistance and leukemic stem cell persistence
    Soltani I et al. Comput Biol Chem, February 2026

      Asciminib and pulsed ATRA as post-remission therapy in T3151I mutated PML_RARA-positive blast crisis of chronic myeloid leukemia
    Mazzarella R et al. Ann Hematol, February 2026 
    – open access publication


     

    Quantitative reverse transcription PCR compared with high-resolution melting for simultaneous detection and quantification of four isoforms of BCR::ABL1
    Zhou T et al. J Clin Pathol, February 2026

    Dual proteasome and histone deacetylase inhibition overcomes tyrosine kinase inhibitor resistance in breakpoint cluster region: Abdelson 1-driven leukaemia cell lines
    Okabe S et al. J Cell Mol Med, February 2026 
    – open access publication
     

    January 2026
    Randomized phase 3 trial of Ropeginterferon alpha-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX)
    Burchert A et al. Leukemia, January 2026
    (epub ahead of print) 
    – open access publication
    Hsp-70 Bim interaction mediated mitophagy as a potential therapeutic target for CML stem cells
    Song T et al. Stem Cell Reports, January 2026 
    – open access publication
    Ponatinib for CML patients in routine clinical practice: the PONDEROSA study
    Schenk T et al. Ann Hematol, January 2026 
    – open access publication
    Enhanced detection of splice-altering variants in hematologic malignancies using targeted RNA-sequencing data
    Maqsood M et al. J Mol Diagn, January 2026
     
    Risk factors and reasons for switching from front-line therapy in the Italian CML network: A cohort study
    Breccia M et al. Br J Haematol, January 2026
    (epub ahead of print)
    Identification of a Mushashi2 translocation as a novel oncogene in myeloid leukemia
    Spinler K et al. Elife, January 2026 
    – open access publication
     
    Treatment-free remission after two nilotinib consolidation durations in chronic myeloid leukemia treated with imatinib: Phase 3 ENESTPath results
    Réa D et al. Leukemia, January 2026 (epub ahead of print)
    Quantitative reverse transcription PCR completed with high-resolution melting for simultaneous detection and quantification of four isoforms of BCR::ABL1
    Zhou T et al. J Clin Pathol, January 2026
    (epub ahead of print)
     
    Management of chronic myeloid leukemia during pregnancy: Review of evidence and treatment algorithm
    Haddad FG et al. Clin Lymphoma Myeloma Leuk,
    January 2026
    Sequential BCR::ABL1 evaluation during dose de-escalation in peripheral blood is more predictive of TFR success than single assessment at dose de-escalation in either peripheral blood or bone marrow
    Patterson SD et al. Blood, January 2026
    (epub ahead of print) 
    – open access publication 

    Real-world outcomes with low-dose dasatinib (50 mg) in imatinib-resistant chronic myeloid leukemia chronic-phase: A retrospective analysis of efficacy and safety
    Gangadaran N et al. Cancer Rep (Hobokken),
    January 2026 
    – open access publication

    Mmrn1 expression defines a novel subset of hematopoietic stem cells and leukemia stem cells with great self-renewal potential
    Chen N et al. Haematologica, January 2026
    (epub ahead of print) 
    – open access publication
     
    Evaluating the safety of combining tyrosine kinase inhibitors with anticoagulants in chronic myeloid leukemia: A systematic review
    Gameil A et al. Oncology, January 2026
    (epub ahead of print) 
    – open access publication
     
    One-year consolidation with ponatinib 15 mg in chronic myeloid leukemia on deep molecular response with imatinib
    Pérez-Lamas L et al. Ann Hematol, January 2026 
    – open access publication
     
    Prediction of relapse after discontinuation of tyrosine kinase inhibitor treatment in chronic myeloid leukemia
    Ross DM. Leuk Lymphoma, January 2026
    (epub ahead of print)
     
    Introduction to a How I Treat series on chronic myeloid leukemia
    Gotlib J. Blood January 2026
     
    How I treat advanced phases of CML
    Mauro MJ. Blood, January 2026
     
    How I evaluate and treat resistance and relapse in CML
    Soverini S and Castagnetti F. Blood, January 2026
     
    How I individualize frontline treatment for chronic phase CML
    Leyte-Vidal A and Shah NP. Blood, January 2026
     
    How I approach hematopoietic stem cell transplantation for CML in a TKI world
    Chalandon Y et al. Blood, January 2026
     
    How I manage chronic myeloid leukemia during pregnancy 
    Abruzzese E, Chelysheva E. Blood January 2026
     
    Advances of next-generation STAMP inhibitors in chronic myeloid leukemia
    Costa A and Breccia M. Expert Opin Investig Drugs, January 2026 
     
    Drug resistance in chronic myeloid leukemia: The involvement of Galectin-1 and Galectin-3
    Yildirim C. Mol Biol Rep, January 2026
     
    Sequential BCR::ABL1 evaluation during dose de-escalation in peripheral blood is more predictive of TFR success than single assessment at dose de-escalation in either peripheral blood or bone marrow
    Patterson SD et al. Leukemia, January 2026
    (epub ahead of print) 
    – open access publication
     
    An overview of chronic myeloid leukemia treatment:
    From tyrosine kinase inhibitors to novel and emerging therapies

    Sekar AJ et al. Eur J Haematol, January 2026 (epub ahead of print) 
    – open access publication
     

    Influence of pharmacokinetics-related polymorphisms on asciminib exposure in patients with Japanese chronic myeloid leukemia
    Takahashi N et al. Eur J Clin Pharmacol, January 2026

     
    Specifically targeting the ABL myristoyl pocket: STAMP inhibitors for chronic myeloid leukemia
    Ureshino H and Kimura S. Expert Rev Hematol, January 2026 
    (epub ahead of print)

    Find publications on pediatric CML here
    Find publications on COVID-19 and CML here
    Find CML publications from the emerging regions here

    CML Publications 2014-2025


    Would you like to suggest an interesting paper or article? >> Please provide us with the details here and we will be happy to review your suggestion!

    Search for more publications on CML at PubMed.gov